p53 Overexpression in synovial tissue from patients with early and longstanding rheumatoid arthritis compared with patients with reactive arthritis and osteoarthritis

Arthritis and Rheumatism

Volumn 42, Issue 5, 1999, Pages 948-953

  Tak, Paul P ^a,b   Smeets, Tom J M ^b   Boyle, David L ^a   Kraan, Maarten C ^b   Shi, Yan ^a   Zhuang, Shunrong ^a   Zvaifler, Nathan J ^a   Breedveld, Ferdinand C ^b   Firestein, Gary S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ADULT; AGED; ARTICLE; CHRONIC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE OVEREXPRESSION; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; OSTEOARTHRITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REACTIVE ARTHRITIS; RHEUMATOID ARTHRITIS;

EID: 0032958824     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(199905)42:5<948::AID-ANR13>3.0.CO;2-L     Document Type: Article

References (25)

1. Firestein GS, Yeo M, Zvaifler NJ. Apoptosis in rheumatoid arthritis synovium. J Clin Invest 1995;96:1631-8.
2. Firestein GS, Nguyen K, Aupperle KR, Yeo M, Zvaifler NJ. Apoptosis in rheumatoid arthritis: p53 overexpression in rheumatoid arthritis synovium. Am J Pathol 1996;149:2143-51.
3. Nakajima T, Aono H, Hasunuma T, Yamamoto K, Shirai T, Hirohata K, Nishioka K. Apoptosis and functional Fas antigen in rheumatoid arthritis synoviocytes. Arthritis Rheum 1995;38:485-91.
4. Matsumoto S, Muller-Ladner U, Gay RE, Nishioka K, Gay S. Ultrastructural demonstration of apoptosis, Fas and Bcl-2 expression of rheumatoid synovial fibroblasts. J Rheumatol 1996;23: 1345-52.
5. Sionov RV, Haupt Y. Apoptosis by p53: mechanisms, regulation, and clinical implications. Springer Semin Immunopathol 1998;19: 345-62.
6. Nickels A, Selter H, Pfreundschuh M, Montenarh M, Koch B. Detection of p53 in inflammatory tissue and lymphocytes using immunohistology and flow cytometry: a critical comment. J Clin Pathol 1997;50:654-60.
7. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
8. Altman R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K, et al. Development of criteria for the classification and reporting of osteoarthritis: classification of osteoarthritis of the knee. Arthritis Rheum 1986;29:1039-49.
9. Kraan MC, Versendaal H, Jonker M, Bresnihan B, Post WJ, 't Hart BA, et al. Asymptomatic synovitis precedes clinically manifest arthritis. Arthritis Rheum 1998;41:1481-8.
10. Tak PP, Smeets TJM, Daha MR, Kluin PM, Meijers KAE, Brand R, et al. Analysis of the synovial cell infiltrate in early rheumatoid synovial tissue in relation to local disease activity. Arthritis Rheum 1997;40:217-25.
11. Tak PP, Kummer JA, Hack CE, Daha MR, Smeets TJM, Erkelens GW, et al. Granzyme-positive cytotoxic cells are specifically increased in early rheumatoid synovial tissue. Arthritis Rheum 1994;37:1735-43.
12. Baas IO, Mulder JW, Offerhaus GJ, Vogelstein B, Hamilton SR. An evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival colorectal neoplasms. J Pathol 1994;172:5-12.
13. Bonsing BA, Corver WE, Gorsira MC, van Vliet M, Oud PS, Cornelisse CJ, et al. Specificity of seven monoclonal antibodies against p53 evaluated with Western blotting, immunohistochemistry, confocal laser scanning microscopy, and flow cytometry. Cytometry 1997;28:11-24.
14. King G, Payne S, Walker F, Murray GI. A highly sensitive detection method for immunohistochemistry using biotinylated tyramine. J Pathol 1997;183:237-41.
15. Zvaifler NJ, Boyle D, Firestein GS. Early synovitis: synoviocytes and mononuclear cells. Semin Arthritis Rheum 1994;23:11-6.
16. Soden M, Rooney M, Cullen A, Whelan A, Feighery C, Bresnihan B. Immunohistological features in the synovium obtained from clinically uninvolved knee joints of patients with rheumatoid arthritis. Br J Rheumatol 1989;28:287-92.
17. Aupperle KR, Boyle DL, Hendrix M, Zvaifler NJ, Barbosa M, Firestein GS, et al. Regulation of synoviocyte proliferation, apoptosis and invasion by the p53 tumor suppressor gene. Am J Pathol 1998;152:1091-8.
18. Firestein GS, Echeverri F, Yeo M, Zvaifler NJ, Green DR. Somatic mutations in the p53 tumor suppressor gene in rheumatoid arthritis synovium. Proc Natl Acad Sci U S A 1997;94:10895-900.
19. Reme T, Travaglio A, Gueydon E, Adla L, Jorgensen C, Sany J. Mutations of the p53 tumour suppressor gene in erosive rheumatoid synovial tissue. Clin Exp Immunol 1998;111:353-8.
20. Wink DA, Kasprzak KS, Maragos CM, Elespuru RK, Misra M, Dunamus TM, et al. DNA deaminating ability and genotoxicity of nitric oxide and its progenitors. Science 1991;254:1001-3.
21. McInnes IB, Leung BP, Field M, Wei XQ, Huang FP, Sturrock RD, et al. Production of nitric oxide in the synovial membrane of rheumatoid and osteoarthritis patients. J Exp Med 1996;184:1519-24.
22. Maurice MM, Nakamura H, van der Voort EAM, Leow A, Versendaal J, Yodoi J, et al. Increased expression of thioredoxin in rheumatoid arthritis [abstract]. Arthritis Rheum 1998;41 Suppl 9:S319.
23. Ihling C, Menzel G, Wellens E, Monting JS, Schaefer HE, Zeiher AM. Topographical association between the cyclin-dependent kinases inhibitor P21, p53 accumulation, and cellular proliferation in human atherosclerotic tissue. Arterioscler Thromb Vasc Biol 1997;17:2218-24.
24. Ponten F, Berne B, Ren ZP, Nister M, Ponten J. Ultraviolet light induces expression of p53 and p21 in human skin: effect of sunscreen and constitutive p21 expression in skin appendages. J Invest Dermatol 1995;105:402-6.
25. Tak PP, Zvaifler NJ, Green DR, Firestein GS. Rheumatoid arthritis and p53: how oxidative stress might alter the course of inflammatory diseases. Immunol Today. In press.